In the News
Xconomy: West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More
We were stuck for a couple days in a Nobel vortex. Speculation about a Nobel Prize in chemistry for University of California, Berkeley scientist Jennifer Doudna and her gene-editing research partner, Emmanuelle Charpentier, swirled and swirled until everyone following it got a bit dizzy.
Berkeley News: Doudna receives Women in Science Award from L’Oreal-UNESCO
UC Berkeley professor Jennifer Doudna, who invented a gene-editing tool that has taken the research world by storm, was named one of five laureates of the 2016 L’Oréal-UNESCO for Women in Science Awards in the field of life sciences.
Chemical & Engineering News: The 2015 Top 20 Drugs in the Pipeline
While anticipation mounts that the FDA may rubber stamp a gene therapy technique for the first time within the next couple of years, excitement about a new, simple and highly-precise gene editing technique is reaching fever pitch.
Chemical & Engineering News: Genome Editing Writ Large
Information pouring in from accurate, low-cost gene-sequencing machines is allowing scientists to pose more and better genomic questions. But in the absence of easy-to-use genome-editing tools to experiment with, answers have been hard to come by. Starting to bridge this gap is a three-year-old editing approach called CRISPR/Cas9.
The Economist: The Age of the Red Pen
It is now easy to edit the genomes of plants, animals and humans. In the summer of 2005 Karen Aiach and her husband received heartbreaking news about their four-month-old daughter, Ornella: she had a rare disorder known as Sanfilippo syndrome.